SOUTHAMPTON, Pa., June 12 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's ("ETC" or the "Company") BioMedical Division today announced that the Malaysian Department of Safety & Health (DOSH) has certified the BARAMED(R) monoplace hyperbaric chamber for use in Malaysia. This is the first U.S. manufactured computer controlled monoplace chamber to receive such a certification.
ETC worked closely with our Malaysian distributor, Alif Harmonis S/B, to help ensure that the hyperbaric chamber passed all certification requirements. Obtaining DOSH certification clears the way for further sales of BARA-MED(R) chambers in Malaysia.
ETC is the manufacturer of the BARA-MED(R) and BARA-MED(R) XD, the industry's most technically advanced hyperbaric chambers. These chambers include a 4th generation Windows(R) based operating system which controls and records chamber activity. ETC hyperbaric chambers remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time. ETC's hyperbaric chambers are regularly used for clinical treatments at medical facilities around the world.
Eric Sprague, Director of Asia Sales for ETC, commented, "The Asian Market is very important to ETC's monoplace expansion plans."
The BioMedical Division continues to evolve its HBOT applications. The BARA-MED and BARA-MED XD are examples of ETC's ability to combine practical value with state-of-the-art technology. For further information on ETC hyperbaric chambers and how our chambers could benefit your HBOT (Hyperbaric Oxygen Therapy) programs please visit our website http://www.etcbiomedical.com.
ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.
This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward- looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC's and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) the proposed acquisition of the Company by Lenfest, a member of ETC's Board of Directors and a significant shareholder, (ii) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward- looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10-K, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.
The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.
Contact: Duane D. Deaner, CFO Tel: 215-355-9100 (ext. 1203) Fax: 215-357- 4000 ETC-Internet Home Page: http://www.etcusa.com
CONTACT: Duane D. Deaner, CFO, +1-215-355-9100 ext. 1203, Fax: +1-215-
357-4000
Web site: http://www.etcusa.com/
http://www.etcbiomedical.com/
